Trademark: 79285864
Status Date
Tuesday, December 7, 2021
Registration Number
6578319
Registration Date
Tuesday, December 7, 2021
Filing Date
Wednesday, December 18, 2019
Published for Opposition
Tuesday, September 21, 2021
5 Pharmaceutical preparations for the treatment of pain, appetite loss, epilepsy and seizures, glaucoma, sleep disorders, muscle spasms, nausea, gastrointestinal disorders, cancer, Alzheimer's disease, symptoms of post-traumatic stress disorder, anxiety, depression, schizophrenia, addiction disorder, inflammation, multiple sclerosis, pre-menstrual syndrome; medicinal preparations for the treatment of pain, appetite loss, epilepsy and seizures, glaucoma, sleep disorders, muscle spasms, nausea, gastrointestinal disorders, cancer, Alzheimer's disease, symptoms of post-traumatic stress disorder, anxiety, depression, schizophrenia, addiction disorder, inflammation, multiple sclerosis, pre-menstrual syndrome; herbal preparations and extracts for medicinal use; medical cannabis and derivatives thereof namely, medicinal herbs and medicinal herb extracts; herbal supplements; all of the foregoing containing or solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD
35 Retail and wholesale store services featuring cannabis medicinal herbs, cannabis oil and derivatives thereof all of the foregoing containing or solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; retail and wholesale store services featuring hemp and cannabis cosmetic products and accessories, food products, beverages, personal care preparations, and skin care preparations, all of the foregoing containing or solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; providing consumer information featuring the ratings, reviews and recommendations on marijuana and medical marijuana products via a website
1 Active chemical ingredients for use in the manufacture of pharmaceuticals solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD
44 Cultivation of plants for others featuring solely cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; consultancy services relating to the cultivation of plants; cultivation and breeding for others of cannabis all of the foregoing containing or solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; providing health and agricultural information in the field of medical marijuana and cannabis via a website; providing medical information featuring indications and effects of particular cannabis strains, the benefits of medical marijuana, marijuana, cannabis and research related to cannabis and marijuana via a website
Dec 2, 2022
New Representative At Ib Received
Jul 5, 2022
Final Decision Transaction Processed By Ib
May 23, 2022
Final Disposition Notice Sent To Ib
May 23, 2022
Final Disposition Processed
Mar 7, 2022
Final Disposition Notice Created, To Be Sent To Ib
Jan 8, 2022
Change Of Name/Address Rec'd From Ib
Dec 18, 2021
New Representative At Ib Received
Dec 7, 2021
Registered-Principal Register
Nov 14, 2021
Notification Of Possible Opposition - Processed By Ib
Oct 27, 2021
Notification Of Possible Opposition Sent To Ib
Oct 27, 2021
Notification Of Possible Opposition Created, To Be Sent To Ib
Oct 4, 2021
Notification Processed By Ib
Sep 21, 2021
Official Gazette Publication Confirmation E-Mailed
Sep 21, 2021
Published For Opposition
Sep 1, 2021
Notification Of Possible Opposition Sent To Ib
Sep 1, 2021
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Sep 1, 2021
Notification Of Notice Of Publication E-Mailed
Aug 19, 2021
Approved For Pub - Principal Register
Aug 16, 2021
Examiner's Amendment Entered
Aug 12, 2021
Notification Of Examiners Amendment E-Mailed
Aug 12, 2021
Examiners Amendment E-Mailed
Aug 12, 2021
Examiners Amendment -Written
Jul 15, 2021
Examiner's Amendment Entered
Jul 15, 2021
Assigned To Lie
Jul 15, 2021
Notification Of Examiners Amendment E-Mailed
Jul 15, 2021
Examiners Amendment E-Mailed
Jul 15, 2021
Examiners Amendment -Written
Jun 4, 2021
Teas/Email Correspondence Entered
Jun 4, 2021
Correspondence Received In Law Office
Jun 4, 2021
Teas Request For Reconsideration Received
Apr 29, 2021
Notification Of Final Refusal Emailed
Apr 29, 2021
Final Refusal E-Mailed
Apr 29, 2021
Final Refusal Written
Mar 30, 2021
Teas/Email Correspondence Entered
Mar 30, 2021
Correspondence Received In Law Office
Mar 30, 2021
Teas Response To Office Action Received
Oct 18, 2020
Refusal Processed By Ib
Sep 30, 2020
Non-Final Action Mailed - Refusal Sent To Ib
Sep 30, 2020
Refusal Processed By Mpu
Sep 10, 2020
Non-Final Action (Ib Refusal) Prepared For Review
Sep 9, 2020
Non-Final Action Written
Sep 9, 2020
Assigned To Examiner
Jun 2, 2020
Application Filing Receipt Mailed
May 28, 2020
Assigned To Examiner
May 27, 2020
Assigned To Examiner
May 27, 2020
New Application Office Supplied Data Entered In Tram
May 21, 2020
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
